# ENTYVIO
> **BLA761359** · Biologics License Application · Sponsor: TAKEDA PHARMS USA · Approved 2024-04-18
## Drug
- **FDA Application Number:** BLA761359
- **Application type:** Biologics License Application
- **Brand name:** ENTYVIO
- **Generic name:** Vedolizumab
- **Active ingredients:** VEDOLIZUMAB
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** TAKEDA PHARMS USA
- **First approval:** 2024-04-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761359)
---
*MORVS · CC0 1.0*